pmid	doi	year	title	Hugo_Symbol
28690313	10.1038/leu.2017.216	2019	The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.	WAC
